Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila

b toxicity and highlight Grp78 as a novel therapeutic target for the treatment of AD

• Publication year

  2016

• Venue

  Current Biology

• Publication date

  2016-09-26

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/j.cub.2016.09.018PMID 27676294PMCID 5628945
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Amyloid-b peptide protects against microbial infection in mouse and worm models of Alzheimer’s disease

  2016cited by this paper
• Increased Glucose Transport into Neurons Rescues Aβ Toxicity in Drosophila

  2016cited by this paper
• Metformin increases APP expression and processing via oxidative stress, mitochondrial dysfunction and NF-κB activation: Use of insulin to attenuate metformin's effect.

  2015cited by this paper
• GLUT1 reductions exacerbate Alzheimer's disease vasculo-neuronal dysfunction and degeneration

  2015cited by this paper
• Association of Insulin Resistance With Cerebral Glucose Uptake in Late Middle-Aged Adults at Risk for Alzheimer Disease.

  2015cited by this paper
• Loss of PLA2G6 leads to elevated mitochondrial lipid peroxidation and mitochondrial dysfunction

  2015cited by this paper
• The loss of glucose-regulated protein 78 (GRP78) during normal aging or from siRNA knockdown augments human alpha-synuclein (α-syn) toxicity to rat nigral neurons.

  2015cited by this paper
• Pharmacologic screens reveal metformin that suppresses GRP78-dependent autophagy to enhance the anti-myeloma effect of bortezomib

  2015cited by this paper
• World Alzheimer Report 2015 - The Global Impact of Dementia: An analysis of prevalence, incidence, cost and trends

  2015influential reference
• Glial Glycolysis Is Essential for Neuronal Survival in Drosophila.

  2015cited by this paper
• Changes in [18F]Fluoro-2-deoxy-d-glucose incorporation induced by doxorubicin and anti-HER antibodies by breast cancer cells modulated by co-treatment with metformin and its effects on intracellular signalling

  2015cited by this paper
• Cytotoxicity study on SH‑SY5Y cells cultured at high glucose levels and treated with bupivacaine.

  2014cited by this paper
• The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress

  2014cited by this paper
• Improved and expanded Q-system reagents for genetic manipulations

  2014influential reference
• Disturbance of endoplasmic reticulum proteostasis in neurodegenerative diseases

  2014influential reference
• Alzheimer's

  2014cited by this paper
• Proteostasis and Secondary Proteinopathy in Alzheimer's Disease

  2014cited by this paper
• Insulin, IGF-1 and GLP-1 signaling in neurodegenerative disorders: targets for disease modification?

  2014cited by this paper
• Statins, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, potentiate the anti-angiogenic effects of bevacizumab by suppressing angiopoietin2, BiP, and Hsp90α in human colorectal cancer

  2014cited by this paper
• Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin

  2013cited by this paper
• Early Decline in Glucose Transport and Metabolism Precedes Shift to Ketogenic System in Female Aging and Alzheimer's Mouse Brain: Implication for Bioenergetic Intervention

  2013cited by this paper
• Intracellular accumulation of toxic turn amyloid-β is associated with endoplasmic reticulum stress in Alzheimer's disease.

  2013cited by this paper
• Sex and ApoE Genotype Differences in Treatment Response to Two Doses of Intranasal Insulin in Adults with Mild Cognitive Impairment or Alzheimer's Disease

  2013cited by this paper
• Comparative Analysis of the Expression Patterns of UPR-Target Genes Caused by UPR-Inducing Compounds

  2013cited by this paper
• Unfolded protein response in Gaucher disease: from human to Drosophila

  2013cited by this paper
• Modeling Alzheimer's disease with iPSCs reveals stress phenotypes associated with intracellular Aβ and differential drug responsiveness.

  2013cited by this paper
• Generative FDG-PET and MRI Model of Aging and Disease Progression in Alzheimer's Disease

  2013cited by this paper
• Activation of AMPK by the Putative Dietary Restriction Mimetic Metformin Is Insufficient to Extend Lifespan in Drosophila

  2012influential reference
• Region-Specific Hierarchy between Atrophy, Hypometabolism, and β-Amyloid (Aβ) Load in Alzheimer's Disease Dementia

  2012cited by this paper
• The Role of Glucose Transporters in Brain Disease: Diabetes and Alzheimer’s Disease

  2012influential reference
• The ER stress factor XBP1s prevents amyloid-beta neurotoxicity.

  2011cited by this paper
• Incidence of Dementia is Increased in Type 2 Diabetes and Reduced by the Use of Sulfonylureas and Metformin

  2011cited by this paper
• Using the Q system in Drosophila melanogaster

  2011cited by this paper
• Inhibition of GSK-3 Ameliorates Aβ Pathology in an Adult-Onset Drosophila Model of Alzheimer's Disease

  2010cited by this paper
• Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease.

  2009cited by this paper
• pySolo: a complete suite for sleep analysis in Drosophila

  2009cited by this paper
• Promoting basal levels of autophagy in the nervous system enhances longevity and oxidant resistance in adult Drosophila

  2008cited by this paper
• The unfolded protein response regulator GRP78/BiP is required for endoplasmic reticulum integrity and stress-induced autophagy in mammalian cells

  2008cited by this paper
• Using FlyAtlas to identify better Drosophila melanogaster models of human disease

  2007cited by this paper
• Hofbauer-Buchner Eyelet Affects Circadian Photosensitivity and Coordinates TIM and PER Expression in Drosophila Clock Neurons

  2007cited by this paper
• アルツハイマー病の早期診断に向けて-米国 Alzheimer's Disease Neuroimaging Initiative の取り組み

  2006cited by this paper
• Electrical Hyperexcitation of Lateral Ventral Pacemaker Neurons Desynchronizes Downstream Circadian Oscillators in the Fly Circadian Circuit and Induces Multiple Behavioral Periods

  2006cited by this paper
• Insulin regulates neuronal glucose uptake by promoting translocation of glucose transporter GLUT3.

  2006cited by this paper
• Increased risk of Alzheimer's disease in Type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology?

  2005cited by this paper
• 2-NBDG as a fluorescent indicator for direct glucose uptake measurement.

  2005cited by this paper
• The unfolded protein response is activated in Alzheimer’s disease

  2005cited by this paper
• Intraneuronal Abeta, non-amyloid aggregates and neurodegeneration in a Drosophila model of Alzheimer's disease.

  2005cited by this paper
• Orchestrating the unfolded protein response in health and disease.

  2002cited by this paper
• BiP is feed-back regulated by control of protein translation efficiency.

  2002cited by this paper
• Signal analysis of behavioral and molecular cycles

  2002cited by this paper
• A conditional tissue-specific transgene expression system using inducible GAL4

  2001influential reference
• Altered Electrical Properties in DrosophilaNeurons Developing without Synaptic Transmission

  2001cited by this paper
• Dynamic interaction of BiP and ER stress transducers in the unfolded-protein response

  2000cited by this paper
• Tissue-specific expression of dominant negative mutant Drosophila HSC70 causes developmental defects and lethality.

  1999cited by this paper
• ALZHEIMER'S DISEASE INTERNATIONAL

  1997cited by this paper
• The glucose-regulated proteins (GRP78 and GRP94): functions, gene regulation, and applications.

  1994cited by this paper
• Cellular mechanism of metformin action involves glucose transporter translocation from an intracellular pool to the plasma membrane in L6 muscle cells.

  1992cited by this paper
• Alzheimer's disease: the amyloid cascade hypothesis.

  1992cited by this paper

• Effect of antidiabetic drugs in Alzheimer´s disease: a systematic review of preclinical and clinical studies

  2025cites this paper
• Amyloid-beta induces distinct forms of cell death in different neuronal populations.

  2025cites this paper
• The emerging role of disulfidptosis in Alzheimer's disease.

  2025cites this paper
• Andrographolide modulates glucose metabolism in visceral adipose tissue in an Alzheimer's disease obese mouse model

  2025cites this paper
• Human Glucose Transporters in Health and Selected Neurodegenerative Diseases

  2025cites this paper
• Glucose uptake in pigment glia suppresses Tau-induced inflammation and photoreceptor degeneration

  2025cites this paper
• Essential conserved neuronal motors kinesin-1 and kinesin-3 regulate Aβ42 toxicity in vivo

  2024cites this paper
• Metabolic gatekeepers: Dynamic roles of sugar transporters in insect metabolism and physiology

  2024cites this paper
• Ketone body metabolism and cardiometabolic implications for cognitive health

  2024cites this paper
• PTPRJ is a negative regulator of insulin signaling in neuronal cells, impacting protein biosynthesis, and neurite outgrowth

  2024cites this paper
• Glut1 Functions in Insulin-Producing Neurons to Regulate Lipid and Carbohydrate Storage in Drosophila

  2024cites this paper
• Emerging role of Metformin in Alzheimer's disease: A translational view.

  2024cites this paper
• Tea polyphenol ameliorates memory impairment in aged type 2 diabetic rats by modulating hippocampal glucose uptake/metabolism and O-GlcNAc glycosylation/phosphorylation of Tau

  2024cites this paper
• A comparison of carbon dot and CdTe quantum dot toxicity in Drosophila melanogaster

  2024cites this paper
• Beneficial effects of metformin treatment on memory impairment

  2024cites this paper
• A Retrospective Analysis of Central and Peripheral Metabolic Characteristics in Patients with Cryptococcal Meningitis

  2024cites this paper
• Using Drosophila amyloid toxicity models to study Alzheimer's disease

  2024influential citation
• Neuropathogenesis-on-chips for neurodegenerative diseases

  2024cites this paper
• Interactions between nanoparticles and pathological changes of vascular in Alzheimer's disease.

  2024cites this paper
• Unveiling the impact of Aging on BBB and Alzheimer's disease: Factors and Therapeutic implications.

  2024cites this paper
• Protein retention in the endoplasmic reticulum rescues Aβ toxicity in Drosophila

  2023influential citation
• Deciphering mechanisms of action of ACE inhibitors in neurodegeneration using Drosophila models of Alzheimer’s disease

  2023cites this paper
• Amyloid-β specific regulatory T cells attenuate Alzheimer’s disease pathobiology in APP/PS1 mice

  2023cites this paper
• Blood-brain barrier transporters: An overview of function, dysfunction in Alzheimer's disease and strategies for treatment.

  2023cites this paper
• Drug–drug interactions between propofol and ART drugs: Inhibiting neuronal activity by affecting glucose metabolism

  2023cites this paper
• Proteomic alterations in the brain and blood–brain barrier during brain Aβ accumulation in an APP knock-in mouse model of Alzheimer’s disease

  2023cites this paper
• Adiponectin and resistin modulate the progression of Alzheimer´s disease in a metabolic syndrome model

  2023cites this paper
• Glycometabolic Reprogramming of Microglia in Neurodegenerative Diseases: Insights from Neuroinflammation

  2023cites this paper
• Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease

  2023cites this paper
• A new perspective on HIV: effects of HIV on brain-heart axis

  2023cites this paper
• Apolipoprotein ε in Brain and Retinal Neurodegenerative Diseases

  2023cites this paper
• A diabetes-like biochemical and behavioural phenotype of Drosophila induced by predator stress

  2023cites this paper
• Association Between Metformin and Alzheimer’s Disease: A Systematic Review and Meta-Analysis of Clinical Observational Studies

  2022cites this paper
• Exploring the dual character of metformin in Alzheimer's disease.

  2022cites this paper
• Deciphering the Roles of Metformin in Alzheimer’s Disease: A Snapshot

  2022cites this paper
• Characterization of Gfat1 (zeppelin) and Gfat2, Essential Paralogous Genes Which Encode the Enzymes That Catalyze the Rate-Limiting Step in the Hexosamine Biosynthetic Pathway in Drosophila melanogaster

  2022cites this paper
• Differential gene expression by RNA-seq during Alzheimer's disease-like progression in the Drosophila melanogaster model.

  2022cites this paper
• Age- and Sex-Associated Glucose Metabolism Decline in a Mouse Model of Alzheimer’s Disease

  2022cites this paper
• Lithium Enhances Hippocampal Glucose Metabolism in an In Vitro Mice Model of Alzheimer’s Disease

  2022cites this paper
• Dysfunctional Glucose Metabolism in Alzheimer’s Disease Onset and Potential Pharmacological Interventions

  2022cites this paper
• Effect of cx-DHED on Abnormal Glucose Transporter Expression Induced by AD Pathologies in the 5xFAD Mouse Model

  2022cites this paper
• Targeting Alzheimer’s Disease: The Critical Crosstalk between the Liver and Brain

  2022cites this paper
• Progressive development of melanoma-induced cachexia differentially impacts organ systems in mice

  2022cites this paper
• Naturally Occurring SGLT2 Inhibitors: A Review.

  2021cites this paper
• Expression of glucose transporters in human neurodegenerative diseases.

  2021cites this paper
• Impact of Genetic Risk Factors for Alzheimer’s Disease on Brain Glucose Metabolism

  2021cites this paper
• Increasing neuronal glucose uptake attenuates brain aging and promotes life span under dietary restriction in Drosophila

  2021cites this paper
• Therapies for Alzheimer's disease: a metabolic perspective.

  2021cites this paper
• Activating transcription factor 4-dependent lactate dehydrogenase activation as a protective response to amyloid beta toxicity

  2021cites this paper
• A Systematic Review of Glucose Transport Alterations in Alzheimer's Disease

  2021cites this paper
• Disruption of Endoplasmic Reticulum Proteostasis in Age-Related Nervous System Disorders.

  2021cites this paper
• Brain Glucose Transporters: Role in Pathogenesis and Potential Targets for the Treatment of Alzheimer’s Disease

  2021cites this paper
• Aβ toxicity rescued by protein retention in the ER

  2021cites this paper
• Brain adiponectin signaling controls peripheral insulin response in Drosophila

  2021cites this paper
• Disruption of Glucose Metabolism in Aged Octodon degus: A Sporadic Model of Alzheimer's Disease

  2021cites this paper
• Liposome-based Strategies to Mitigate Ischemic Stroke-induced Neurodegeneration

  2021cites this paper
• CD4+ effector T cells accelerate Alzheimer’s disease in mice

  2021cites this paper
• Genome-Wide Association Study of Brain Alzheimer’s Disease-Related Metabolic Decline as Measured by [18F] FDG-PET Imaging

  2020cites this paper
• Partial Inhibition of RNA Polymerase I Promotes Animal Health and Longevity

  2020cites this paper
• Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention

  2020cites this paper
• Glucose, glycolysis, and neurodegenerative diseases

  2020cites this paper
• Proteotoxicity and Mitochondrial Dynamics in Aging Diabetic Brain.

  2020cites this paper
• Increasing glucose uptake into neurons antagonizes brain aging and promotes health and life span under dietary restriction in Drosophila

  2020cites this paper
• PICALM rescues glutamatergic neurotransmission, behavioural function and survival in a Drosophila model of Aβ42 toxicity

  2020cites this paper
• Neuronostatin Promotion Soluble Aβ1-42 Oligomers: Induced Dysfunctional Brain Glucose Metabolism in Mice

  2020cites this paper
• Ketotherapeutics for neurodegenerative diseases

  2020cites this paper
• Insulin resistance and bioenergetic manifestations: Targets and approaches in Alzheimer's disease.

  2020cites this paper
• Andrographolide restores glucose uptake in rat hippocampal neurons

  2020cites this paper
• Metformin delays neurological symptom onset in a mouse model of neuronal complex I deficiency

  2020cites this paper
• Glucose metabolism: A link between traumatic brain injury and Alzheimer’s disease

  2020cites this paper
• The db mutation improves memory in younger mice in a model of Alzheimer's disease.

  2019cites this paper
• Metabolic aspects of neuronal degeneration: From a NAD+ point of view.

  2019cites this paper
• Could metformin be therapeutically useful in Huntington’s disease?

  2019cites this paper
• Timing Matters: Circadian Effects on Energy Homeostasis and Alzheimer's Disease.

  2019cites this paper
• Dynamic changes in the brain protein 1 interaction network correlates with 2 progression of Aβ42 pathology in 3 Drosophila 4

  2019cites this paper
• Effects of progesterone on glucose uptake in neurons of Alzheimer's disease animals and cell models.

  2019cites this paper
• Manipulating mtDNA in vivo reprograms metabolism via novel response mechanisms

  2019cites this paper
• Multi-Loop Model of Alzheimer Disease: An Integrated Perspective on the Wnt/GSK3β, α-Synuclein, and Type 3 Diabetes Hypotheses

  2019cites this paper
• Xenobiotic mediated diabetogenesis: Developmental exposure to dichlorvos or atrazine leads to type 1 or type 2 diabetes in drosophila.

  2019cites this paper
• A positive feedback loop between Myc and aerobic glycolysis sustains tumor growth in a Drosophila tumor model

  2019cites this paper
• Lactate Deficit in an Alzheimer Disease Mouse Model: The Relationship With Neuronal Damage

  2018cites this paper
• Dynamic changes in the brain protein interaction network correlates with progression of Aβ42 pathology in Drosophila

  2018cites this paper
• jouvence, a new small nucleolar RNA required in the gut extends lifespan in Drosophila

  2018influential citation
• Tracking dynamic changes in Alzheimer’s disease brain proteome reveals ageing-independent damage in Drosophila

  2018cites this paper
• Implications of Successful Symptomatic Treatment in Parkinson's Disease for Therapeutic Strategies of Alzheimer's Disease.

  2018cites this paper
• Wnt‐induced activation of glucose metabolism mediates the in vivo neuroprotective roles of Wnt signaling in Alzheimer disease

  2018cites this paper
• Hallmarks of Brain Aging: Adaptive and Pathological Modification by Metabolic States.

  2018cites this paper
• Metabolic Dysfunction in Alzheimer’s Disease: From Basic Neurobiology to Clinical Approaches

  2018cites this paper
• Glial lipid droplets and neurodegeneration in a Drosophila model of complex I deficiency

  2018cites this paper
• Pluripotent Stem Cells for Uncovering the Role of Mitochondria in Human Brain Function and Dysfunction.

  2018cites this paper
• Dissecting Endoplasmic Reticulum Unfolded Protein Response (UPRER) in Managing Clandestine Modus Operandi of Alzheimer’s Disease

  2018cites this paper
• Sense and antisense RNA are not toxic in Drosophila models of C9orf72-associated ALS/FTD

  2018cites this paper
• Astrocytic transporters in Alzheimer's disease.

  2017cites this paper
• Progressing neurobiological strategies against proteostasis failure: Challenges in neurodegeneration.

  2017cites this paper
• Metabolic study of Alzheimer’s disease using mutant C. elegans

  2017cites this paper
• A network of insulin peptides regulate glucose uptake by astrocytes: Potential new druggable targets for brain hypometabolism.

  2017cites this paper
• RNA polymerase III limits longevity downstream of TORC1

  2017cites this paper
• Drosophila Neprilysin 1 Rescues Memory Deficits Caused by Amyloid-β Peptide

  2017cites this paper
• Genome-wide analysis reveals distinct genetic mechanisms of diet-dependent lifespan and healthspan in D. melanogaster

  2017cites this paper
• Metformin – a Future Therapy for Neurodegenerative Diseases

  2017cites this paper